Lupin, Dr Reddy’s recall 1.7 lakh blood pressure, acidity tablets in US
Lupin Pharmaceuticals Inc -- is recalling 59,520 bottles of Lisinopril & Hydrochlorothiazid tablets USP 20mg/12.5mg, 5,880 bottles of Lisinopril tablets The post Lupin, Dr Reddy’s recall 1.7 lakh...
View ArticleLupin receives US FDA nod to market Voriconazole tablets for fungal treatment
The company said it shall commence promoting the products in the US shortly The post Lupin receives US FDA nod to market Voriconazole tablets for fungal treatment appeared first on Firstpost.
View ArticleGlenmark’s US arm receives US FDA approval for contraceptive tablets
New Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estradiol tablets. In a BSE filing, the company said...
View ArticleWarning letters for pharma cos galore: Now Cadila Healthcare faces USFDA...
The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility The post Warning letters for pharma cos galore: Now Cadila Healthcare faces...
View ArticleSun Pharma shares plunge on USFDA warning letter to its Halol plant
Fresh warning letter to the company issued on Saturday comes after the facility was first inspected by the US drug regulator in September 2014 The post Sun Pharma shares plunge on USFDA warning letter...
View ArticleDr Reddy’s issues clarification to USFDA’s warning letter for its two units
Last month, the company had received a warning letter from the USFDA relating to two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana The post Dr Reddy’s issues...
View ArticleDr Reddy’s gets a breather after USFDA gives more time to respond to warning...
The country's second-largest drug maker last week said it received a warning letter from the US drug regulator relating to two of its API manufacturing plants and a formulation plant located in Andhra...
View ArticleUS FDA sounds import ban on Dr Reddy’s drugs for several violations
The regulator said it had found several violations with regard to current good manufacturing practices (CGMP) at three of its plants The post US FDA sounds import ban on Dr Reddy’s drugs for several...
View ArticleDr Reddy’s shares tank 12% after US FDA issues warning letter to AP,...
Dr Reddy's API manufacturing facilities at Srikakulam in Andhra Pradesh and Miryalaguda in Telangana were issued warning letter, besides an oncology unit in AP also received the letter The post Dr...
View ArticleGlenmark gets tentative USFDA approval for Lacosamide tablets
Lacosamide Tablets is generic version of Vimpat Tablets of UCB Inc The post Glenmark gets tentative USFDA approval for Lacosamide tablets appeared first on Firstpost.
View ArticleFDA approves immunotherapy drug to fight lung cancer
The US Food and Drug Administration (FDA) on Friday approved the drug Keytruda to treat the most common form of lung cancer. The post FDA approves immunotherapy drug to fight lung cancer appeared first...
View ArticleDr Reddy’s flares up 6% after launching generic drug of nexium in US
Dr Reddy's stock outperformed the BSE Healthcare index, which was up 0.5 percent The post Dr Reddy’s flares up 6% after launching generic drug of nexium in US appeared first on Firstpost.
View ArticleSun Pharma arm inks deal to buy US firm InSite Vision for $48 million
Co to make a tender offer for all issued and outstanding common stocks of InSite Vision at $0.35 per share in cash The post Sun Pharma arm inks deal to buy US firm InSite Vision for $48 million...
View ArticleWireless pacemaker may offer surgery-free alternative, but questions over...
A tiny, wireless pacemaker could offer some heart patients a surgery-free alternative to the traditional devices, a new study says. Some doctors, however, say there are lingering safety questions. The...
View ArticleSeveral pharma shares scale new 52-week highs in a flattish broad market
Shares of Aurobindo Pharma, Cadila Healthcare, Glenmark Pharma, JB Chemicals & Pharmaceuticals, Jubilant Life Sciences, Unichem Laboratories and Coral Laboratories scaled new one-year highs on BSE...
View ArticleIndia-made food products face USFDA heat, Haldiram’s top list of rejected items
According to the data tabled in the United States Food and Drug Administration (FDA) website, more food products from India have been rejected in the US in 2015 than that from any other country. The...
View ArticleWockhardt recalls 12-15 drugs from US market; shares tumble up to 11%
The company clarified to CNBC-TV18 that it has taken measures to resolve the FDA's concerns The post Wockhardt recalls 12-15 drugs from US market; shares tumble up to 11% appeared first on Firstpost.
View ArticleFresenius Kabi files suit against Claris Lifesciences over anesthesia drug
Claris Lifesciences today said US-based Fresenius Kabi has filed a suit against the company to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or...
View ArticleNovartis sues Cipla for infringing respiratory drug patent
Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original...
View ArticleUS FDA cracks down on Dr Reddy’s Andhra plant
The US Food and Drug Administration (FDA) has found nine possible procedural deviations in a manufacturing plant of Dr Reddy's Laboratories during a recent inspection and has sought reply from the drug...
View Article
![[-100%] Commodity Intelligence – (Android Apps)](http://play-lh.googleusercontent.com/j67-qJvmnn4xnVlYVZ9ZhtZUJIgwjKekJGoKQT6D1KHcWGZxtQaFroummEvwV17na7tyh1pGbbeWCRdWtTKqeg=w950-h950)
